Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Identification of immunostimulatory antigens in Group A <i><i>Streptococcus</i></i>-derived vesicles.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse.

Animals : an open access journal from MDPI·2025

Same author

Neutralisation of the Immunoglobulin-Cleaving Activity of <i>Streptococcus equi</i> Subspecies <i>equi</i> IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine.

Vaccines·2025

Same author

Impact of SARS-CoV-2 variant mutations on susceptibility to monoclonal antibodies and antiviral drugs: a non-systematic review, April 2022 to October 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025

Same author

Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024

Search research articles

Related Experiment Video

Updated: Jun 8, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Streptococcus pneumoniae epidemiology, pathogenesis and control.

Ana Rita Narciso¹, Rebecca Dookie¹, Priyanka Nannapaneni¹

¹Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Nature Reviews. Microbiology

|November 7, 2024

Summary

Streptococcus pneumoniae infections are a major health threat. New strategies targeting epidemiology, pathogenesis, and antibiotic resistance are crucial for controlling pneumococcal disease, especially in unvaccinated groups.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Related Experiment Videos

Last Updated: Jun 8, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

Area of Science:

Microbiology
Infectious Diseases
Vaccinology

Background:

Streptococcus pneumoniae causes significant respiratory and invasive diseases.
Pneumococcal conjugate vaccines reduced disease in children but increased non-vaccine type infections.
Antibiotic resistance and disease in unvaccinated populations necessitate new control strategies.

Purpose of the Study:

To review recent findings on pneumococcal epidemiology, genomics, and pathogenesis.
To explore new therapeutic and preventive strategies against pneumococcal infections.
To inform future control strategies for pneumococcal disease.

Main Methods:

Review of clinical data and pathogenesis studies.
Analysis of epidemiological trends and genomic data.
Evaluation of vaccine impact and emerging resistance patterns.

Main Results:

Increased infections from non-vaccine pneumococcal types in unvaccinated populations.
Emerging antibiotic resistance poses a therapeutic challenge.
Advances in understanding pathogenesis offer potential for novel therapies.

Conclusions:

Novel approaches are essential for combating Streptococcus pneumoniae.
Exploiting host-pathogen interactions may lead to new treatments.
Future control strategies require integrated approaches considering vaccines, resistance, and pathogenesis.